Reactive arthritis is joint inflammation triggered not by an infection inside the joint itself, but by an infection somewhere else in the body, most often the gut or the urogenital tract. Symptoms typically appear one to three weeks after the original infection and tend to hit the large joints of the lower limbs asymmetrically. The condition sits within the broader family of spondyloarthritis, and while it resolves on its own for many people, a significant minority deal with lingering symptoms for years.
What Triggers It
The most common culprits fall into two camps: foodborne gut infections and sexually transmitted urogenital infections. On the enteric side, Campylobacter, Salmonella, and Shigella are the usual suspects. A systematic review pooling data from published outbreaks found that roughly 9 to 12 out of every 1,000 people infected with one of these bacteria went on to develop reactive arthritis.1PubMed Central. Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, salmonella and Shigella-associated reactive arthritis That means it’s uncommon after any single bout of food poisoning, but given how widespread these infections are globally, it adds up to a real patient population.
On the urogenital side, Chlamydia trachomatis is the dominant trigger. Chlamydia-triggered reactive arthritis tends to develop one to three weeks after a genital infection and can occur even when the initial chlamydia symptoms were mild or went unnoticed.2PubMed Central. Persistent infection of Chlamydia in reactive arthritis Yersinia species round out the classic list, though they are more commonly recognized in Northern Europe than in other regions.
In children, the trigger list gets broader and stranger. Case reports have documented reactive arthritis following infections with parasites like Giardia and pinworm, as well as viruses including rotavirus, enteroviruses, and even SARS-CoV-2.3Quality in Sport. Reactive Arthritis in Children: A Literature Review with Analysis of Uncommon Infectious Triggers and Clinical Presentations These atypical triggers are worth knowing about because pediatric reactive arthritis is easy to miss if clinicians are only looking for the classic bacterial causes.
How It Presents in the Joints
The textbook presentation is an asymmetric oligoarthritis, meaning a few joints are affected and not in a mirrored pattern. The knees and ankles take the brunt of it most often, though the feet and toes can also be involved. Patients may also develop enthesitis, which is pain and swelling where tendons and ligaments attach to bone, commonly at the Achilles tendon or the sole of the foot. Dactylitis, colloquially called “sausage digit,” is another hallmark: an entire finger or toe swells uniformly rather than just the joint itself.4PubMed. Reactive arthritis: a clinical review
Sacroiliitis, or inflammation of the sacroiliac joints at the base of the spine, can show up as well and contributes to the lower back stiffness some patients report.5PubMed. Reactive arthritis: a clinical review When back involvement becomes prominent and persistent, the condition starts to resemble ankylosing spondylitis, which is a related but distinct diagnosis within the spondyloarthritis spectrum.
Beyond the Joints
Reactive arthritis is not just an arthritis. Many patients develop extra-articular symptoms that can be confusing if you don’t know to expect them.
- Eyes: Conjunctivitis is the most common ocular feature and often mild, causing redness and a gritty sensation. Some patients develop the more serious iritis (inflammation inside the eye), which causes pain and light sensitivity and needs prompt treatment to prevent vision problems.
- Urinary tract: Urethritis can accompany both urogenital-triggered and enteric-triggered reactive arthritis, meaning it can appear even when the original infection was a gut bug. This is confusing for patients and doctors alike, because urethritis after food poisoning isn’t what anyone expects.
- Skin: Keratoderma blennorrhagicum, a rash of thick, scaly patches on the palms and soles that looks nearly identical to pustular psoriasis, is the most characteristic skin finding.6PubMed Central. A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report Balanitis circinata, painless shallow ulcers on the head of the penis, is another distinctive feature in men.7BMJ Case Reports. Keratoderma blennorrhagica
- Mouth: Painless oral ulcers can appear and are easy to dismiss as unrelated.
The old clinical triad of arthritis, urethritis, and conjunctivitis (“can’t see, can’t pee, can’t climb a tree,” as the medical mnemonic goes) captures the classic picture, but not every patient presents with all three features. Many have arthritis alone, and the extra-articular symptoms may come and go on their own timeline.
The Role of HLA-B27
HLA-B27 is a protein on the surface of cells that helps the immune system distinguish self from foreign invaders. Carrying the HLA-B27 gene doesn’t mean you’ll get reactive arthritis, but it makes the condition more likely to develop and tends to influence how it behaves. In a retrospective study comparing HLA-B27-positive and HLA-B27-negative reactive arthritis patients, those who carried the gene were more prone to spinal and sacroiliac involvement, while those without it tended to have more upper-extremity and small-joint disease.8PubMed Central. HLA-B27 negative reactive arthritis versus HLA-B27 positive reactive arthritis: A retrospective study
Research into how HLA-B27 actually contributes has pointed toward molecular mimicry. When HLA-B27 presents fragments of bacterial proteins to immune cells, some of those fragments closely resemble the body’s own proteins. This resemblance may trick the immune system into attacking joint tissue even after the original infection has been dealt with.9Journal of Biological Chemistry. Endogenous Processing and Presentation of Chlamydial Peptides by HLA-B27 The resulting autoimmune-like loop could explain why some patients’ symptoms persist long after the triggering infection has cleared and why HLA-B27-positive patients are more likely to develop chronic disease.
Why the Joints Are “Sterile” but Not Clean
One of the more puzzling aspects of reactive arthritis is that you typically cannot grow live bacteria from the affected joint fluid. That’s what separates it from septic arthritis, where bacteria are actively multiplying inside the joint. Yet the joint is not truly free of microbial traces. Sensitive molecular techniques have repeatedly detected bacterial DNA in the synovial fluid and tissue of reactive arthritis patients. In one study of 28 synovial tissue samples, bacterial DNA was found in three quarters of them, including DNA from known reactive arthritis triggers like Shigella flexneri and Shigella sonnei that were absent in control samples.10PubMed Central. Analysis of bacterial DNA in synovial tissue of Tunisian patients with reactive and undifferentiated arthritis by broad-range PCR, cloning and sequencing
For chlamydia-triggered disease specifically, researchers have found not just DNA but also ribosomal RNA and bacterial lipopolysaccharide in the joint, suggesting the organisms are not merely dead remnants but are persisting in a dormant, metabolically altered form.11PubMed Central. Persistent infection of Chlamydia in reactive arthritis This persistent, cryptic infection may act as a continuing stimulus for the immune response. The concept is important because it informs the debate about whether antibiotics could help in chlamydia-triggered cases, an idea that remains unsettled.
Getting to a Diagnosis
There is no single definitive test for reactive arthritis. Diagnosis is clinical, built on the combination of a recent infection followed by characteristic joint inflammation, with or without the extra-articular features described above. Blood tests often show elevated inflammatory markers, and HLA-B27 testing can support the diagnosis, but a negative result does not rule it out.
The main diagnostic challenge is distinguishing reactive arthritis from septic arthritis, which requires urgent treatment. Septic arthritis usually involves a single hot, swollen joint along with fever and signs of severe systemic illness.12PubMed. Diagnosis and classification of reactive arthritis Joint aspiration is often performed to check for bacteria and crystals. Interestingly, the white blood cell count in the joint fluid can be quite high in reactive arthritis, sometimes overlapping with the levels seen in true bacterial joint infection, which can muddy the picture.13PubMed. Synovial fluid leukocytosis in bacterial arthritis vs. reactive arthritis and rheumatoid arthritis in the adult knee Gram stain and culture of the fluid ultimately separate the two: sterile in reactive arthritis, positive in septic arthritis.
Testing for the triggering infection itself is useful when possible. Stool cultures or PCR for enteric pathogens, and urine or swab-based nucleic acid testing for chlamydia, can confirm the preceding infection. However, by the time joint symptoms appear, the original infection may have already cleared, so a negative test doesn’t exclude the diagnosis.
Treatment
First-line treatment revolves around controlling inflammation and pain. Nonsteroidal anti-inflammatory drugs are the backbone, and clinical experience strongly supports their use, though the formal trial evidence is limited to a couple of small studies.14PubMed Central. Treating reactive arthritis: insights for the clinician Corticosteroid injections directly into a swollen joint can provide rapid relief when one or two joints are particularly troublesome. Oral corticosteroids are sometimes used for more widespread disease, though controlled trials specifically in reactive arthritis are lacking.
The role of antibiotics is one of the more debated questions. For enteric-triggered reactive arthritis, antibiotics given after the joint symptoms appear have not shown clear benefit in trials. For chlamydia-triggered disease, the picture is slightly more encouraging, and some clinicians will prescribe a course of antibiotics, particularly if there is evidence of persistent chlamydial infection. The trial data, however, remain mixed enough that there is no consensus recommendation.15PubMed Central. Treating reactive arthritis: insights for the clinician
When symptoms persist beyond a few months despite NSAIDs and corticosteroids, disease-modifying agents like sulfasalazine or methotrexate may be tried. For truly refractory cases, biologic agents that block specific inflammatory cytokines, such as tumor necrosis factor inhibitors, have been used. The evidence base for biologics in reactive arthritis is thin, however, consisting mostly of case reports and small series rather than controlled trials.16PubMed Central. Treatment of reactive arthritis with biological agents: a review For the skin manifestation of keratoderma blennorrhagicum specifically, there is emerging interest in JAK inhibitors, though the evidence so far comes from individual case reports.17PubMed Central. A novel approach with tofacitinib for the management of keratoderma blennorrhagicum in reactive arthritis: a case report
Prognosis and the Chronicity Problem
The standard reassurance is that reactive arthritis is self-limiting. For many patients that’s true: symptoms improve within three to six months and may disappear entirely within a year. But the reality is messier than the reassurance. In a case-control study with two-year follow-up, nearly half of reactive arthritis patients still had ongoing symptoms at the two-year mark.18PubMed Central. Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up That is a much higher chronicity rate than most patients expect to hear.
What predicts who will recover quickly and who won’t is still not well worked out. HLA-B27 positivity appears to be one risk factor for a prolonged course, and the same study found that patients whose symptoms persisted had lower levels of a particular enzyme involved in tissue remodeling at the time of diagnosis.19PubMed Central. Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up That biomarker finding is interesting but not yet useful in clinical practice. In the meantime, patients who still have active symptoms after three to six months should be discussing disease-modifying therapy with their rheumatologist rather than simply waiting it out.
Cardiac Involvement
This is the complication most patients don’t know to worry about, and in fairness, it’s uncommon. But longstanding reactive arthritis, particularly in HLA-B27-positive patients, has been linked to aortic valve insufficiency and conduction abnormalities in the heart. A case report and literature review described a 43-year-old man who had lived with reactive arthritis for 19 years before developing severe aortic insufficiency that required valve replacement surgery.20PubMed Central. Aortic insufficiency in a patient with reactive arthritis: case report and review of the literature The combination of aortic regurgitation and electrical conduction problems in HLA-B27-positive patients has been described as a distinct cardiac syndrome worth watching for in this population.
For most patients with a brief, self-limited episode, cardiac screening is not standard. But for anyone with chronic reactive arthritis, especially those who are HLA-B27-positive, periodic echocardiography is a reasonable precaution. A new heart murmur or unexplained fatigue in someone with long-running disease should prompt evaluation.
Post-Streptococcal Reactive Arthritis
Streptococcal throat infections can also trigger a reactive arthritis that is distinct from both classic reactive arthritis and the more feared acute rheumatic fever. Post-streptococcal reactive arthritis tends to present as a persistent, nonmigratory joint inflammation without the cardiac inflammation (carditis) that defines rheumatic fever, and it generally resolves without lasting damage.21PubMed. Acute rheumatic fever and Post-streptococcal reactive arthritis The distinction matters because the treatment and follow-up differ: rheumatic fever requires long-term antibiotic prophylaxis to prevent recurrent cardiac damage, while post-streptococcal reactive arthritis may not need the same aggressive prevention strategy, though guidelines on this vary by region.
Why “Reiter’s Syndrome” Fell Out of Use
If you encounter older medical literature or hear the term from an older clinician, you may come across “Reiter’s syndrome” as a synonym for the classic triad of arthritis, urethritis, and conjunctivitis. The name comes from Hans Reiter, a German physician who described the triad in 1916. What became clear decades later was that Reiter had been a physician leader in the Nazi party and was directly involved in the regime’s racial hygiene program, including forced sterilization, euthanasia, and medical experiments on concentration camp prisoners.22PubMed. Declining use of the eponym “Reiter’s syndrome” in the medical literature, 1998-2003
Beginning in the late 1990s, physicians argued that continuing to honor Reiter’s name in medical terminology was ethically unacceptable.23PubMed. Reactive arthritis–the appropriate name The shift was gradual but measurable: the unqualified use of the Reiter eponym in published medical articles dropped from about 57% in 1998 to 34% by 2003.24PubMed. Declining use of the eponym “Reiter’s syndrome” in the medical literature, 1998-2003 Today, “reactive arthritis” is the standard term in guidelines and textbooks. The name change also happens to be more clinically useful, since it describes the mechanism of the disease rather than anchoring it to one historical description of a triad that not all patients display.25PubMed. Reactive arthritis: the convoluted history of Reiter’s disease